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T cell ontogeny is a sophisticated process, which takes place within the thymus through a
series of well-defined discrete stages.The process requires a proper lympho-stromal inter-
action. In particular, cortical and medullary thymic epithelial cells (cTECs, mTECs) driveT cell
differentiation, education, and selection processes, while the thymocyte-dependent signals
allow thymic epithelial cells (TECs) to maturate and provide an appropriate thymic microen-
vironment. Alterations in genes implicated in thymus organogenesis, includingTbx1, Pax1,
Pax3, Pax9, Hoxa3, Eya1, and Six1, affect this well-orchestrated process, leading to dis-
ruption of thymic architecture. Of note, in both human and mice, the primordial TECs are
yet unable to fully support T cell development and only after the transcriptional activation
of the Forkhead-box n1 (FOXN1) gene in the thymic epithelium this essential function is
acquired. FOXN1 is a master regulator in the TEC lineage specification in that it down-
stream promotes transcription of genes, which, in turn, regulate TECs differentiation. In
particular, FOXN1 mainly regulates TEC patterning in the fetal stage and TEC homeostasis
in the post-natal thymus. An inborn null mutation in FOXN1 leads to Nude/severe com-
bined immunodeficiency (SCID) phenotype in mouse, rat, and humans. In Foxn1−/− nude
animals, initial formation of the primordial organ is arrested and the primordium is not col-
onized by hematopoietic precursors, causing a severe primary T cell immunodeficiency. In
humans, the Nude/SCID phenotype is characterized by congenital alopecia of the scalp,
eyebrows, and eyelashes, nail dystrophy, and a severe T cell immunodeficiency, inherited
as an autosomal recessive disorder. Aim of this review is to summarize all the scientific
information so far available to better characterize the pivotal role of the master regulator
FOXN1 transcription factor in the TEC lineage specifications and functionality.
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INTRODUCTION
The thymus is the primary lymphoid organ with the unique func-
tion to produce and to maintain the pool of mature and functional
T cells. This process is strictly dependent on specialized func-
tions of thymic stromal cells (TSCs) and requires the thymus
peculiar tridimensional (3D) architecture, which allows a proper
intercellular cross talk (1). For a long time, the difficulty in the iso-
lation and characterization of the thymic cellular components has
limited studies on the peculiar role of individual stromal compo-
nents. Novel experimental tools, including stromal cell isolation by
phenotype-based cell sorting (2), dissociation and reaggregation
of stromal cell subsets (3, 4), or global gene expression analysis
and the evaluation of the pattern of self-antigen expression within
the individual thymic epithelial cells (TECs) subset (5), allowed to
acquire important knowledge on the cellular and molecular basis
of thymus organogenesis and TECs functionality.
The recent discovery of disease models associated to genetic
alterations of molecules implicated in thymus specification and
TECs differentiation,provided new and conclusive insights regard-
ing the pathways, the genes, and the molecular mechanism
governing these processes and stromal functionality.
THE THYMUS ARCHITECTURE: REQUIREMENT OF A 3D
STRUCTURE FOR A PROPER LYMPHO-EPITHELIAL
CROSSTALK
The thymus provides the microenvironment essential for the
development of T cells. T cell progenitors originate in the bone
marrow, enter into the thymus (6, 7) and, through a series of
well defined and coordinated developmental stages, differentiate,
undergo selection process, and mature into functional T cells.
The steps in this process are tightly regulated through a complex
network of transcriptional events, specific receptor-ligand inter-
actions, and sensitization to trophic factors, which mediate the
homing, proliferation, survival, and differentiation of developing
T cells (1, 8, 9).
The thymus is organized in two lobes, which are already present
in mice at 21 days of thymic organogenesis and is completely
organized at 1 month of post-natal life. The lobes are divided
in three areas: a cortical and the dark cortical area, with a high
number of lymphoid cells and epithelial cells, cortical thymic
epithelial cells (cTECs); a light medullary area with a low number
of mature T cells, named medullary TECs (mTECs), Hassall’s bod-
ies (HB), macrophages, dendritic cells (DCs), B lymphocytes, and
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rarely myoid cells. Eventually, there is a transitional area, named
cortico-medullary junction (CMJ), characterized by abundant
blood vessels (10).
The unique function of the thymus in the establishment and
maintenance of the T cell pool is intimately linked to this peculiar
thymus architecture and to the specialized functions of the TSCs.
LYMPHO-EPITHELIAL CROSS-TALK REQUIRED FOR
THYMOCYTE AND TECs DIFFERENTIATION
An important feature of the thymic microenvironment is its
3D organization, consisting of an ordered architecture of TSCs,
that represents a heterogeneous mixture of distinct cell types,
including cTECs, mTECs, fibroblasts, endothelial cells, DCs, and
macrophages (11). Among these stromal elements, TECs are the
most abundant cell types, which form a delicate 3D cellular
network spanning throughout both the thymic cortex and the
medulla. The requirement for the 3D-supporting stroma appears
to be unique to the T cell development, as the in vitro differenti-
ation program of other hematopoietic lineages, including B and
NK cells, does not require a 3D structure (12).
Thymocyte development is not a cell-autonomous process, and
the transition to the next stage in development relies on the proper
interaction of HSCs with thymic stroma. The 3D configuration
of the thymus maximizes this interaction, allowing intercellular
cross-talk integral to the development of both T cells and TSCs
(13). Paralleling the T cell precursor proliferation and differentia-
tion program, immature TECs undergo a developmental sequence,
resulting in the establishment of mature cTECs and mTECs orga-
nized in this 3D network. Several studies on mutant mice with
an abnormal organization of thymic epithelium substantiated the
concept that a reciprocal signaling between thymocytes and TSCs
is required, not only for the production of mature T cells but
also for the development and organization of the thymic microen-
vironment in a bi-directional fashion (14, 15). Mice showing a
blockage of the T cell development process, in the absence of T
cell receptor (TCR)-expressing cells, have a defective organiza-
tion of the thymic medulla, as well (16, 17). Of note, under this
condition, thymic medullary organization can be restored by the
addition of mature T cells, which follows stem cell transplanta-
tion (17, 18). In adult CD3etg26 mice, lacking intra-thymic T
cell precursors, a severe alteration of the cortical thymic archi-
tecture has been documented (19), even though a restoration of
the architecture and TEC development in these mice can occur.
Recently, the injection of either fetal or adult T-committed pre-
cursors into adult CD3etg26 mice leads to the reconstitution of
thymic microenvironment, as indicated by thymocyte differen-
tiation, organization of functional cortical and medullary areas,
and generation of Foxp3+ Treg and Aire+ mTECs (20). These
data suggest that adult TECs maintain the receptivity to cross talk
with thymocytes despite a prolonged absence of T cell precursors.
Moreover, the absence of both thymocytes and of the 3D frame-
work may result in changes of the keratin genes expression, thus
inducing the cTECs and mTECs to undergo a de-differentiation
process and to reacquire the precursor K5+K8+ cellular pheno-
type. Taken together, these findings suggest that signals from early
CD4–CD8– DN T cell precursors and/or their immediate prog-
eny provide necessary signals to promote the formation of the
thymic cortex, while, later in ontogeny, the differentiation of TECs
into a medullary phenotype are clearly dependent on the presence
of CD4+CD8− and CD4−CD8+ single positive (SP) thymocytes
(21–23). However, the precise molecular nature of the signals pro-
vided by developing thymocytes, which lead to the generation of
the thymic stromal compartment are still incompletely defined.
Eventually, a better understanding of the developmental process
through which a normal thymus structure is built, is essential
for a better comprehension of the intimate mechanisms which
take place within the thymus to promote the T cell development
in vivo. This knowledge may also be useful in designing future
therapeutic strategies, as alterations of the thymus structure and
function may result in serious health consequences, including
immunodeficiency or autoimmunity.
mTECS AND cTECS ARE SPECIALIZED CELLS PLAYING A
DIFFERENT ROLE IN THE T CELL EDUCATION PROCESS
T cell ontogeny is a sophisticated process, which takes place
through discrete stages during which developing thymocytes
dynamically relocate in different thymic areas, following a cortico-
medullary gradient.
The initial colonization of the thymus anlagen by migrant lym-
phoid progenitors occurs at an early stage, embryonic day 11.5
(E11.5) in mice and 8 week of gestation in humans (24, 25). Stud-
ies documented that chemokines CC ligand (CCL)21 and CCL25
play a major role in the early stage of fetal thymus colonization
(26, 27). Indeed, mice deficient for these chemokines or for the
cognate receptors, showed a significant reduction in the number
of thymocytes compared to normal mice (28). In post-natal thy-
mus, lymphoid progenitor cells through their cell surface adhesion
molecules, such as platelet-selectin glycoprotein ligand 1, inter-
act with P-selectin, expressed on the TECs, and thanks to this
interaction they are allowed to migrate from the blood into the
thymic parenchyma, in correspondence of the area around the
CMJ [Figure 1; (29)].
Entered thymocytes started to intensely proliferate and to
acquire T cell hallmarks. In this phase, T cell proliferation and
differentiation are triggered by a potent combination of signals
provided by cTECs. Delta-like 4 (DL4), which is an essential, non-
redundant ligand for Notch1 during thymic T cell development,
and IL-7 are critically involved in the activation of signaling path-
ways, leading to the proliferation and migration of thymocytes
(30–32). In particular, these intra-thymic ligands induce the devel-
opment of DN CD25+ cells, which migrate toward the subcapsular
region of thymic cortex (33). Several chemokine receptors have
been suggested to guide the migration of immature thymocytes,
such as CXCR4, CCR7, and CCR9 [Figure 1; (34)]. In the thymic
cortex DN thymocytes begin V(D)J rearrangement of their TCRβ
gene. Successfully rearranged TCRβ protein, assembled with the
pre-TCRα chains, forms the pre-TCR complex. Membrane expres-
sion of pre-TCR complex, along with the Delta-Notch interaction,
provides the signal necessary to induce the expression of the co-
receptors CD4 and CD8, as well as V-J rearrangement of the TCRα
genomic region. Subsequently, DP thymocytes with a functional
TCR-αβ receptor are generated [Figure 1; (35)].
Thymic cortex is also the area where takes place the positive
selection of DP thymocytes. Positive selection is the process by
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FIGURE 1 | Lympho-stromal interactions andT cell development. Bone
marrow HSCs enter into the thymus through CMJ, a process mediated by
CCL12 and CCL25 in the embryonic thymus and by the interaction between
P-selectin and its cognate ligand PSGL-1 in adult thymus. Stimulation by IL-7
allows the relocation of DN thymocytes from the cortex to the subcapsular
region. DP thymocytes bearing TCR and capable of binding to self-MHC
ligands are positively selected. This process is regulated by Pssr6 and b5t,
which are expressed in cTECs. Developing thymocytes are relocated from
cortex to the medulla by chemotactic attraction between CCR7 and the
ligands CCL19/CCL21, expressed on the mTECs. Into medulla, self-reactive
thymocytes are deleted through the negative selection, a process mediated
by dendritic cells and Aire-expressing mTECs.
which developing thymocytes, that recognize and bind with mild
avidity peptide-major histocompatibility complex on cTECs sur-
face, get a rescue signal through their TCR and are allowed to
further maturate to the CD4+CD8− or CD4−CD8+ SP stage.
Only a small fraction (1–5%) of DP cells survive to positive selec-
tion. By contrast, the majority of DP cells, that bind with too low
affinity to MHC complex, are programed to undergo death by
neglect (36, 37).
Cortical thymic epithelial cells have a crucial role in the posi-
tive selection process of T cells within thymus cortex (38). Recent
studies have found that cTECs exclusively express a specific form
of proteasome, referred as thymoproteasome, which contains a
peculiar catalytic subunit, the β5-thymus (β5t) (39). β5t subunits
exhibit an unique peptidase activity, compared to other β5 sub-
units found in common immunoproteasome, which leads to the
production of a set of self-peptides with a high affinity for class I
MHC molecules (40). Moreover, β5t-deficient mice show a severe
decrease in the number of CD8+ SP thymocytes, but no alteration
in the CD4+ number or in the thymic architecture. In addition, the
small fraction of CD8+ T cells, positively selected by β5t-deficient
cTECs, show altered immune responses toward several stimuli.
Taken together these results suggest that the thymoproteasome is
essential for the production of self antigens involved in the positive
selection of functional CD4−CD8+ T cells (41).
As for the positive selection of CD4+ T cells, two other pro-
teins predominantly expressed in cTECs, the lysosomal protease
Prss16 and Cathepsin L, have been demonstrated to be essential to
generate an immunocompetent repertoire of CD4+CD8− T cells
[Figure 1; (42, 43)].
TCR engagement by peptide-MHC complex also triggers the
expression of the chemokine receptor CCR7 in positively selected
thymocytes. Thanks to the chemotactic attraction between CCR7
and its ligands, CCL19 and CCL21, expressed on the mTECs,
developing thymocytes are relocated from cortex to the medulla
[Figure 1; (44, 45)].
In order to create a repertoire of mature T cells able to recognize
foreign antigens and, at the meantime, to ignore self antigens, SP
thymocytes have to undergo the negative selection process in the
thymic medulla. Both mTECs and DCs, play a pivotal role in this
last stage of thymocyte development, which is critical to establish
the central tolerance and, eventually, to prevent autoimmunity. In
contrast to cTECs, mTECs are characterized by a high expression
www.frontiersin.org July 2013 | Volume 4 | Article 187 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Romano et al. FOXN1 in thymic epithelial development
of clustered tissue-restricted autoantigens (TSAs), the so called
promiscuous gene expression (46). To date, the autoimmune reg-
ulator (AIRE) transcription factor represents the only molecule,
so far identified, which contributes to the mTECs function and,
in particular, to the molecular regulation of the promiscuous gene
expression [Figure 1; (47)]. However, not all TSAs are regulated
in an AIRE-dependent manner, suggesting that other molecular
mechanisms, such as epigenetic mechanisms, may be involved in
mTECs function regulation. TSAs associated with class II MHC
molecules are presented directly by mTECs or indirectly by DCs
to developing thymocytes (48). T cells which recognize with a high
avidity self antigens are deleted. Remarkably, only a few number
of mTECs express a given TSAs (about 50–500 per thymus), and
lead to apoptosis by negative selection of a few thymocytes (37, 49,
50). A possible explanation is that the high motility of thymocytes
within the thymic medulla during a period of 4–5 days, allows each
of them to interact with mTECs (51). DCs play a similar role in
the negative selection process. They are attracted in the thymic
medulla by the chemochine XCL1 (lymphotactin), produced by
mTECs in an AIRE-dependent manner. Differently from mTECs,
DCs are not able to produce TSAs and the TSAs expressed mostly
derive from the phagocytosis of apoptotic mTECs (52, 53). mTECs
and DCs not only contribute to the establishment of central toler-
ance through the deletion of self-reactive T cells, but, also, through
the generation of regulatory T cells (Tregs) (54, 55, 65, 153), which
act in the periphery by suppressing autoreactive T cells, which have
escaped to the process of the central tolerance.
A body of evidence documents that the expression of an autore-
active TCR leads to the entry of the thymocyte into the Treg lineage.
Tregs, that are about 5–10% of peripheral T cells CD4+, constitu-
tively express the CD25 molecule and share several immunological
features, in humans and mice (56, 57). These cells specifically
express the transcription factor FOXP3 (Foxp3 in mice) that
plays a pivotal role in Tregs differentiation and function (58). The
Foxp3 promoter region and the conserved non-coding sequence 2
(CNS2) (known as TSDR, the Treg-specific-demethylated-region)
are fully methylated in immature thymocytes (59, 155). At the
beginning of Treg development, an appropriate TCR/CD28 signal
is needed to make available the Foxp3 promoter through shift of
the Protein Inhibitors of Activated STAT 1 (PIAS1), a signal cas-
cade, which results in the NF-κB-mediated transcription of genes
playing a role in Treg differentiation (60, 61).
THYMIC FORMATION: NEW INSIGHTS IN EPITHELIAL
LINEAGES SPECIFICATION
In the mouse, mTECs and cTECs originated from the third pha-
ryngeal pouch endoderm and the thymus anlage are located next to
that of the parathyroid. The expression of Forkhead-box transcrip-
tion factor n1 (Foxn1) approximately at E11.5 is crucial for the sub-
sequent epithelial differentiation, since in its absence, the coloniza-
tion of the anlage by T cell progenitors from the bone marrow fails
(62) and the subsequent T cell development and TECs formation is
aborted, resulting in a severe immunodeficiency (63, 64, 66, 154).
The maturation process of TECs during thymic organogen-
esis could be divided in two genetic phases. The first stage is
independent from the Foxn1 expression and consists in the induc-
tion and outgrowth of the thymic epithelial anlage from the third
pharyngeal pouch, through the expression of genes including the
Eya1 and Six (67), Hoxa3 (68), and Tbx1 (69, 70). During the sec-
ond genetic phase, epithelial patterning and differentiation take
place and the Foxn1 expression drives the immature epithelial cells
to differentiate into functional cTECs and mTECs (71).
FOXN1-INDIPENDENT GENETIC STAGE OF TEC
DIFFERENTIATION
In the first phase of the thymus organogenesis an interaction
between epithelial and mesenchymal cells occurs, while at the
later phase lympho-epithelial interaction predominates (72). In
mice, at about E10.5 the mesenchymal cells are able to respond
to the endodermic signals, which induce the development of
the primordial thymic epithelium (73, 74). Subsequently, at
about E12.5, the thymic rudiment is colonized by progenitors
come from the fetal liver, thus resulting in a tight epithelial-
thymocyte interaction within the mesenchymal derived capsule.
This thymic rudiment contains the EpCam+Plet1+ epithelial pop-
ulation (72, 75), which includes a common thymic epithelial
precursor (TEPC), from which both cTECs and mTECs will be
subsequently generated (72, 76).
Through studies on animal models carrying molecular alter-
ations of distinct genes, the key role of several transcription factors
involved in the thymus organogenesis and TEC-sublineage spec-
ification process, have thus far been identified (77). In particular,
several genes, including Tbx1 (69, 70), Pax1, Pax3, Pax9 (78–80),
Hoxa3 (68), Eya1, and Six1 (67) have been shown to play a central
role in the thymus ontogeny. Indeed, their molecular alteration
affects this well-orchestrated process, leading to disruption of the
thymic architecture. Abnormalities of the paired box (Pax) family
transcription factors Pax1 or Pax9 result in a blockage of the thy-
mus organogenesis (79, 81). Mutations in the Hox transcription
factor family member, Hoxa3, expressed on both thymic epithe-
lium and mesenchymal cells, result in athymia (68). Furthermore,
the homozygous loss of Tbx1, related to the DiGeorge syndrome
phenotype, leads to thymic a/hypoplasia in humans (69, 82), while
mice heterozygous for a null allele of Tbx1 show a mild pheno-
type without thymus anomalies (83). Therefore, the expression
of Tbx1 both in the pharyngeal core mesoderm and in the pha-
ryngeal endoderm is required for a proper thymus development.
However, it remains to be elucidated whether the expression of
Tbx1 in the TECs occurs and whether the gene participates in the
TECs development (4).
FOXN1-DEPENDENT GENETIC STAGE OF TEC
DIFFERENTIATION
In both humans and mice, the primordial TECs are yet unable to
fully support T cell development and only after the transcriptional
activation of the FOXN1 gene in the thymic epithelium this essen-
tial function is acquired. FOXN1 is a master regulator in the TEC
lineage development in that it promotes down-stream the tran-
scription of genes implicated in the thymus organogenesis and
TECs full differentiation.
Forkhead-box n1 transcription factor belongs to the FOX tran-
scription factor family implicated in a variety of biochemical and
cellular processes, including development, metabolism, aging, and
cancer (84, 85). During the post-natal life, Foxn1 is selectively
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expressed only in thymic and skin epithelia, where it regulates
the expression of several molecular targets to maintain the bal-
ance between growth and differentiation (86, 87). The signals
required for FOXN1 expression, and its activity, are still unclear,
even though the wingless (Wnt) proteins (88) and bone mor-
phogenetic protein (BMP) signaling have been shown to regulate
FOXN1 expression (89). Even though the complete pattern of
FOXN1 expression over the time and its role are not yet com-
pletely defined, studies on mouse and human model of gene
alterations enormously helped unravel important issues on its role.
Mutations in Foxn1 gene lead to alymphoid cystic thymic dysge-
nesis due to a defective TECs differentiation process (63, 90). In
both mice and humans FOXN1 abnormalities lead to a hairless
phenotype (87, 154).
In the Foxn1-dependent step of thymus organogenesis, precur-
sor epithelial cells differentiate into mature and functional cTECs
and mTECs from the same bi-potential TEC progenitor (4, 72, 76).
It has been reported, that Foxn1 is differentially expressed during
the TE-lineage specification, since it is expressed in all TECs dur-
ing the pre-natal life, but not in all TECs postnatally, indicating
that the gene is highly developmentally regulated. There is a body
of evidence documenting different effects of Foxn1 expression in
mTEC and cTECs. Particularly, studies on K5- and K18-CreERT-
mediated Foxn1-deleted mouse models suggested that during the
post-natal life, the loss of Foxn1 affected mTECs, characterized by
the expression of K5 and K14 keratins type. Conversely, the loss
of Foxn1 did not affect cTECs, which express the keratins K8 and
K18 (91, 92). Taken together, these data suggest that cTECs and
mTECs are not equally Foxn1-dependent in the post-natal life.
Recent reports highlighted a central role for Foxn1 in TECs
homeostasis in the adult thymus and its necessary role for the
functionality and survival of adult TEC progenitors (92), express-
ing K5+ and K14+ markers. This role in adult thymus seems to
be exerted in cooperation with other stem cell-related genes, such
as p63. Of note, the transcription factor p63, encoding for multi-
ple isoforms (93), plays a pivotal for the development of stratified
epithelia of several tissues, such as epidermis, breast, prostate, and
thymus (94). In the thymus, the p63 protein drives the prolifera-
tion of epithelial progenitor cells (94, 95). Therefore, it has been
hypothesized that p63 and Foxn1 could act synergistically through
the formation of a p63-Foxn1 regulatory axis aimed at regulating
TECs homeostasis. However, the molecular mechanism through
which the proliferation regulator p63 and differentiation regulator
Foxn1 collaborate in this axis are still unclear.
FOXN1-MEDIATED GENE EXPRESSION FOR TEC
DIFFERENTIATION
Forkhead-box n1 is directly or indirectly implicated in the tran-
scriptional regulation of a panel of genes involved in thymus
development and function.
Pax1 is a key regulator of TEC differentiation/survival balance.
Pax1 is expressed in the third pharyngeal pouch from E9.5 dur-
ing the thymus ontogeny, while in the post-natal thymus only in
cTEC (96). Even though the regulation of Pax1 is still unclear,
from E11.0 its expression requires Hoxa3 (68). Of note, the loss
of Hoxa3 impairs the intrinsic ability of the neural crest cell pop-
ulation to differentiate and/or to lead to the differentiation of the
tissues of pharyngeal arch and pouch. Indeed, in Hoxa3 mutant
mice the thymus is absent and thyroid hypoplasia has been docu-
mented (68). Moreover, the first step of thymus development is the
expansion of mesenchymal neural crest in the posterior part of the
third pharyngeal pouch. Prior to this event, in the Hoxa3 mutant
embryos a marked reduction in Pax1 expression has been shown.
Similarly, Pax1 mutant mice also show thymic hypoplasia, suggest-
ing a role for Hoxa3 in maintaining Pax1 expression in these cells
(68). In the thymic primordium, Pax1 expression is under the con-
trol of Foxn1 (71). This finding indicates that Foxn1 and Hoxa3 are
both involved in the network of molecular signals that regulates
Pax1 expression, thus demonstrating the existence of a molecular
and/or functional interaction between Hoxa3 and Foxn1 [Figure 2;
(71)]. In keeping with this, Hoxa3+/−Pax1−/− compound mutant
mice display a few phenotypic hallmarks of the Foxn1R/R mouse
model, which expresses low-dose of Foxn1, such as hypomorphic
post-natal thymus, and reduced levels of MHC class II expres-
sion on the TECs surface (80). These data suggest two alternative
hypothesis: Hoxa3 may regulate Foxn1, which, in turn, regulates
Pax1 expression in the thymic primordium, in a Foxn1-dependent
manner, or Hoxa3 and Foxn1 induce Pax1 expression in the third
pharyngeal pouch and in early thymus primordium.
It has also been shown that Foxn1 regulates the expression of
CCL25 and Dll4 (Figure 2). These genes play a pivotal role in the
thymocyte development, since CCL25 regulates the colonization
of the fetal thymus (97), while the Notch ligand Dll4 is involved in
the commitment of hematopoietic progenitors to the T cell lineage
(30). In both early fetal TEC and in the post-natal thymus, Dll4
expression is directly related to the Foxn1 expression (71). Fur-
thermore, these molecules are absent in the Foxn1 null thymus,
even though there is evidence indicating that their expression may
occur in a Foxn1-independent manner in TECs (98, 99). Eventu-
ally, in a recent report it has been shown that Foxn1 is upstream
of dll4a and ccl25a expression in medaka fish, thus confirming the
relationship with this transcription factor (100).
THE HUMAN NUDE/SCID PHENOTYPE: A MODEL OF THYMIC
MICROENVIRONMENT DISRUPTION AND FAILURE OF THE T
CELL DEVELOPMENT
The Nude/severe combined immunodeficiency (SCID) pheno-
type represents the prototype of thymic architecture disruption
due to alterations of the FOXN1, which is the master regulator of
TE-lineage specification (71).
In humans, as in mice and rats, mutations in the “nude” Foxn1
gene induce the hairless phenotype, associated with a rudimen-
tary thymus gland (T cell related primary immunodeficiency).
The human Nude/SCID phenotype (MIM 601705; Pignata Guar-
ino Syndrome) was first identified in 1996, after more than 30 years
from the initial mouse description, in two sisters originated from
a small community with a high grade of inbreeding, who showed
congenital alopecia of the scalp, eyebrows, and eyelashes, nail dys-
trophy, and a severe T cell immunodeficiency, inherited as an
autosomal recessive disorder (154). This phenotype was associ-
ated with a C792T transition in the FOXN1 gene, which resulted
in the nonsense mutation R255X in the exon 4 (formerly exon
5), with a complete absence of a functional protein similar to the
previously described rat and mouse Foxn1 mutations (101–103).
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FIGURE 2 |The thymus organogenesis. The thymus organogenesis is
characterized by two genetic phases. The first stage is independent from
the Foxn1 expression (1) and consists in the induction and outgrowth of
the thymic epithelial anlage from the third pharyngeal pouch, through the
expression of genes including the Eya1, Six, Hoxa3, andTbx1. Hoxa3 and
Eya1 are also required in neural crest cells (NCCs). In the phase 2, Foxn1
regulates the expression of CCL25, Dll4, and Hoxa3, necessary for the
thymocytes and TECs differentiation. During this step, cTECs (expressing
K8 and K18 keratin type) and mTECs (expressing K5 and K14 keratin type)
originate from the same bi-potential TEC progenitor. The crosstalk between
TECs and developing thymocytes is required to generate fully mature TECs
and functional T cells.
In the absence of Foxn1 expression, thymic development is
halted at a rudimentary stage. As a consequence, in the affected
patients the thymic lobe is still present but intra-thymic lym-
phopoiesis is completely blocked (63, 104) leading to severe pri-
mary T cell immunodeficiency (105–107) and to death in early
childhood from severe infections (105, 108–112, 154). Foxn1 is
also involved in morphogenesis and maintenance of the 3D thymic
micro-structure, which is necessary for a fully functional thymus
(113, 114). In fact, evidence is available that in an in vitro 2D
culture system consisting of a monolayer of mouse bone mar-
row stromal OP9 cells it is possible to generate mature T cells,
only if these cells are transduced with the Notch ligand Delta-
like 1 (OP9-DL1) (115, 116), whose pathway exerts a pivotal and
necessary role in promoting the induction of T cell-lineage com-
mitment (117–119). Of note, in all these co-culture systems, the
stromal cells are enforced to overexpress Notch ligands, and their
expression by TECs seems to be maintained only in a 3D thy-
mus structure (120). In human Nude/SCID, the T cell defect is
characterized by the absence of proliferative response to the com-
mon mitogens and a severe blockage of the T cell differentiation
(154). Recent studies revealed the presence of some circulating
T cells of non-maternal origin in patients carrying alterations of
FOXN1 gene. These cells have been shown to be predominantly
double-negativeαβT cells (CD3+CD4−CD8−, DN) and to exhibit
a regulatory like T cell phenotype (FoxP3+). This finding raised
important issues regarding the site of differentiation of these cells.
One hypothesis is the persistence of a thymic rudiment, which
allows a partial T cell development (109). Alternatively, a T cell
differentiation, even though partial and ineffective to result in a
productive immunity, could occur at an extra-thymic site. In both
pre-natal and post-natal life, the TCRBV spectratype repertoire in
Nude/SCID patients is oligoclonal, thus confirming the immatu-
rity of the process and, at the same time, that developmental events
do take place at some extent (111, 112).
For many years, the human counterpart of the nude mouse phe-
notype has been erroneously considered the DiGeorge syndrome,
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which occurs spontaneously and is mainly characterized by thymic
hypo/aplasia and a mild T cell defect. However, several lines of
evidence argue against the analogy between these two disorders.
In fact, the DiGeorge syndrome is often associated with neona-
tal tetany and major anomalies of great vessels. These defects are
due to malformation of the parathyroid and heart, derived from
a major embryologic defect in the third and fourth pharyngeal
pouch from which the thymus primordium emerges. In addition,
in this syndrome hairlessness is missing and gross abnormalities
of skin annexa are not found. Children with DiGeorge syndrome
may also have lymphopenia, with a mild reduction of T cells, that
are however usually responsive to common mitogens.
In Nude/SCID patients, skin is tighter than usual and is charac-
terized by basal hyperplasia and dysmaturity. Alopecia is primitive
in nature, in that it can be observed at birth and persists after bone
marrow transplantation, thus ruling out the acquired nature of the
disorder. In keeping with this, in athymic mice, completely lacking
body hair, restoration of the thymus did not lead to hair growth,
indicating a direct participation of FOXN1 to hair follicle develop-
ment (87). The most frequent phenotypic alteration affecting the
nails is koilonychia (“spoon nail”), characterized by a concave sur-
face and raised edges of the nail plate, associated with significant
thinning of the plate itself; canaliform dystrophy and a transverse
groove of the nail plate (Beau line) may also be observed (121).
However, the most specific phenotypic alteration is leukonychia,
characterized by a typical arciform pattern resembling a half-moon
and involving the proximal part of the nail plate. These alter-
ations of digits and nails were also reported in a few strains of
nude mice. Of note, nail dystrophy has also been observed in het-
erozygous subjects carrying FOXN1 alterations (121). FOXN1 is
known to be selectively expressed in the nail matrix, where the
nail plate originates, thus confirming that this transcription factor
is involved in the maturation process of nails and suggesting nail
dystrophy as an indicative sign of heterozygosity for this molecular
alteration (121).
Autoptical study of a fetus homozygous for R255X muta-
tion revealed multiple-site neural tube defects, including anen-
cephaly and spina bifida. This finding may help explaining the
high rate of mortality in utero observed in the population where
the first patients were identified (105). Intriguingly, the other
forms of SCID become clinically evident only during the post-
natal life, when the protection of the newborn transferred from
the mother immune system declines. This observation, suggests
that other causes different from immunodeficiency, are respon-
sible for the high rate of mortality in utero and led to consider
the Nude/SCID mutation and anencephaly causally related. Of
note, in a recent study, the mouse Foxn1 gene was found to be
expressed also in epithelial cells of the developing choroids plexus,
a structure filling the lateral, third and fourth ventricles of the
embryonic brain (105). Moreover abnormality in the develop-
ment of corpus callosum were also found in another FOXN1
mutated fetus even in the absence of anencephaly, indicating that
the transcription factor may play a role as a co-factor in the brain
ontogeny (105).
Altogether these findings suggest that FOXN1 may also be
implicated as co-factor in the development of vital systems
required for a proper fetus development, thus explaining the
mortality in the first trimester in fetuses carrying the genetic
alterations, which is not justified by the SCID per se.
FOXN1 MUTATION PREVENTS THE PRE-NATAL T CELL
DEVELOPMENT IN HUMANS
It is now clear that FOXN1 acts as a transcription factor impli-
cated in the differentiation of thymic and skin epithelial cells, even
though many of its molecular targets still remain to be discov-
ered. Most of the knowledge so far available has been achieved in
humans in the post-natal life, while little is known about FOXN1
role during the pre-natal life.
Of note, other FOX family members, including Foxq1 and
Foxm1b, are important during embryogenesis, being involved
in a variety of biological processes (122). Approximately 50%
of Foxq1−/− murine embryos die in utero, thus suggesting the
requirement of this gene during embryogenesis (123). Similarly,
Foxm1b is important during liver regeneration (124).
Studies on thymus organogenesis revealed that Foxn1 is
expressed in all TECs during fetal stages. Of note, Foxn1−/−
mice showed undifferentiated TECs responsible for a blockage
of thymopoiesis and severe immunodeficiency (125). Recently,
the identification of a human FOXN1−/− fetus gave the unique
opportunity to study in humans the T cell development in utero,
in the absence of a functional thymus. Vigliano et al. documented a
total blockage of the CD4+ T cell maturation and a severe impair-
ment of CD8+ cells, with an apparent bias toward TCRγδ+ cells
(112). In this case in the congenital absence of the thymus was
due to R255X missense mutation in the FOXN1 gene. In particu-
lar, it has been reported that in the absence of FOXN1 a few not
functional CD8+ cells, mostly bearing TCRγδ in the absence of
CD3, presumably of extra-thymic origin could develop in both
humans and mice (126–128). Further analysis of the fetal RNA,
performed to evaluate the variable-domain β-chain (Vβ) fami-
lies’ usage among T lymphocytes, revealed that the generation of
TCR diversity occurred at some extent in the FOXN1−/− fetus,
but was abnormal. Thus, these data provided a further evidence
of the crucial role for FOXN1 in the early pre-natal stages of T
cell development and not in the B and NK-cell differentiation,
these populations being normally present in the Nude/SCID fetus
(112). A similar impairment of the T cell differentiation with a
selective blockage of CD4 differentiation but not of CD8, was
detected in murine models characterized by the absence of the
nuclear high-mobility group (HMG) box protein TOX (107).
The identification of a limited number of CD8+ cells bear-
ing the TCRγδ suggests that this cell population may develop at
extra-thymic sites in a FOXN1-independent manner, even though
they are unable to sustain a productive immune response into the
periphery. Indeed, evidence exists indicating that T cells may also
differentiate at extra-thymic sites, as intestine and liver (129–133).
Of note, the majority of thymus-derived T lymphocytes bears the
αβ chains of TCR and a few of them express the γδ heterodimer
(134), while the T cell pool developed outside the thymus is char-
acterized by a higher proportion of TCRγδ+ T cells expressing the
CD8αα homodimer, instead of the CD8αβ (135, 136). Moreover,
also DN T cells (CD3+CD4–CD8–) and lymphocytes expressing
CD7 and CD2 in the absence of CD3 (CD2+CD3–CD7+) are
generally considered of extra-thymic origin (135–137).
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In spite of the well documented knowledge on the role of the
primary lymphoid organ to foster T cell development, some still
unsolved issues in human athymic conditions indicate that an in-
depth information of the overall process is still to be achieved and,
in particular, the involvement of different tissues in T cell ontogeny
must be definitively clarified. Since FOXN1 is selectively expressed
in the thymus and skin, one possibility to explain the presence of
the few non-functional CD8+TCRγδ+ cells in Nude/SCID fetus is
that skin epithelial cells could play a partial role in T cell ontogeny,
as already shown in in vitro models (138, 139).
THYMUS TRANSPLANTATION: A PROMISING TREATMENT
TO ATHYMIC DISORDERS
Forkhead-box n1 deficiency is a very rare immunodeficiency with
unfortunately poor chance of curative treatments. Recently, thy-
mus transplantation has emerged as a promising treatment for
children affected with congenital athymia (140–143), as that
observed in complete DiGeorge anomaly and in FOXN1 deficiency.
Conceptually, the thymus transplant seems to be in principle the
more appropriate therapeutic strategy, taking into account that
bone marrow transplantation performed in one child with FOXN1
deficiency, failed to induce a long-term sustained immune recon-
stitution. In particular, in this patient no reconstitution of the
naïve T cell pool was observed (144).
Thymus transplantation has been first used in children affected
with complete DiGeorge anomaly, with excellent clinical and
immunologic results (141). In order to achieve immune recon-
stitution, cultured post-natal allogeneic thymus tissue slices were
transplanted into the quadriceps muscles of the athymic host
(145). The migration of host bone marrow stem cells to the donor
graft allow them to develop into naive T cells, which then emi-
grate out of the engrafted thymic tissue into the peripheral blood.
Thymopoiesis is observed in biopsies of the transplanted thymus
within 2 months of transplantation (140) and naive T cells are
detected in the peripheral blood approximately 3–5 months after
transplantation (146, 147). Taking advantage from this previous
experience, a few years ago an allogeneic thymus transplantation
has been used for the first time in two unrelated infants with
Nude/SCID phenotype due to a deficiency of the transcription
factor FOXN1 (111). The clinical phenotype of the two subjects
was characterized by the absence of naïve T cells, total alope-
cia, nail dystrophy, and severe infections, as disseminated Bacillus
Calmette–Guérin in subject 1 and severe respiratory infections
in subject 2. Molecular analysis, performed to confirm the clin-
ical suspect of the Nude/SCID phenotype, revealed the presence
of a homozygous R255X mutation in the FOXN1 gene in subject
1, the same of that previously described (107), and a homozy-
gous R320W novel missense mutation in the subject 2. Moreover,
subject 1 showed, like a small percentage of complete DiGeorge
patients, referred as atypical complete DiGeorge, circulating oligo-
clonal T cells of non-maternal origins, which were predominantly
double-negative T cells, and a T cell proliferative response to PHA
within the normal range. Because of that, before thymus trans-
plantation subject 1 have required immunosuppression regimen
to prevent graft rejection. Differently, immunosuppression was not
used for the subject 2, who had, like typical complete DiGeorge
patients, very few T cells (141, 146).
Results obtained with thymus transplantation were encourag-
ing in both FOXN1-deficient subjects, and led to a full T and B
cell reconstitution and functional rescue. Indeed, both subjects
developed naïve T cells, diverse TCR repertoires and an in vitro
proliferative T cell responses against different antigens. Eventually
they reached normal serum Ig levels with generation of protective
antibody specific titers. Of note, HLA matching for class I and II
did not seem to interfere with T cell counts after thymus transplan-
tation, being subject 2 transplanted without any HLA matches.
However, CD8+ T cell number, although apparently functional,
was disproportionally low compared to CD4+ T cells (111). A
poor CD8 recovery has also been described in complete DiGeorge
patients, who underwent HLA-mismatched thymic transplanta-
tion (141, 148). Possible explanations are that the phenomenon is
related to the HLA mismatch between host hematopoietic precur-
sors and allograft thymic epithelia or to alterations in the thymic
graft due to transplantation procedures.
Functionality of the thymic allograft has been assessed for
the first time through signal joint (sj) and DβJβ T cell recep-
tor rearrangement excision circle (TREC) analyses (109). The
sj/βTREC represents a ratio between early and late products of
TCR rearrangements, which directly correlate with thymic output
and provide an indirect measurement of thymocyte division-
rate (149–151). The sj/βTREC ratio quantification, conducted
in subject 1 with R255X mutation, was very low during the
peri-transplant period and comparable to those observed in
healthy children at 2.5 years post-transplant. Of note, 4 years post-
transplantation a decrease of sj/βTREC ratio associated with a
reduction in sjTREC levels and in the number of naïve cells
were found, suggesting the decline in thymic allograft output
(109). This decline might be due to the reduced longevity of
the thymus allograft or to peripheral homeostasis of the T cell
pool maintenance following its replenishment. Overall, the thy-
mus transplantation seems to be a promising curative strategy
for subjects with athymia due to FOXN1 deficiency or com-
plete DiGeorge syndrome in the perspective of long-term clinical
benefit.
CONCLUSION
The integrity of the thymic epithelial architecture allows the
growth, the differentiation, and TCR repertoire selection of imma-
ture T cells, thus originating fully mature and functional T cells.
Of note, the failure to generate or to maintain the proper 3D
thymic architecture leads to severe immunodeficiency or autoim-
munity. The unique function of the thymus in the establish-
ment/maintenance of the T cell pool is related not only to the
peculiar 3D structure, but also to the specialized functions of the
thymic stroma. Indeed, lympho-stromal interactions within the
multicellular thymic microenvironment play a crucial role in the
regulation of the T cell development. Moreover, these interactions
are based on a bilateral crosstalk between stromal cells and trav-
eling thymocytes, which, in turn, are able to provide important
signals for the TECs differentiation.
Thymus organogenesis and T cell development are sophisti-
cated biological processes, which require the activation of a wide
panel of genes. There is evidence that the master regulator of
the thymus development is the Foxn1 gene, since it is required at
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multiple intermediate stages of the TE-lineage specification either
in the fetal and adult thymus, through the direct or indirect regu-
lation of genes involved in the thymus development and function.
These genes include Pax1, Hoxa3, CCL25, Dll4, p63.
Studies on the animal and human model of the Nude/SCID
phenotype have provided an enormous contribution in identify-
ing the crucial role of Foxn1 to drive the thymus development,
even though many issues regarding the transcriptional regula-
tion of the TECs specification and homeostasis still remain to be
solved. The development in vitro of cellular models of TEC lineage
differentiation, by using the technology of nuclear reprograming,
will be certainly useful to better characterize the discrete stages of
the TECs differentiation and the molecular mechanism involved
in the process.
Eventually, the in vitro re-build of a thymic environment capa-
ble to reproduce tissue features of primary lymphoid organs (139,
152) could be a promising and valuable tool for the treatment of
congenital athymia, including FOXN1 deficiency, along with the
thymus transplantation, which is emerged as a potential treatment
for these disorders.
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